EXTENDED INTERVAL DOSING OF OCRELIZUMAB REDUCES RISK OF DEVELOPING HYPOGAMMAGLOBULINAEMIA
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined